AG
AGL.US agilon health Inc
- Market cap
- USD 1.85B
- P/E
- -
- P/B
- 6.87x
- ROE
- 39.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is AGL.US undervalued?
Graham numberThe Graham number of agilon health Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
agilon health Inc fundamental analysis
No fundamental analysis for agilon health Inc yet.
agilon health Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About agilon health Inc
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Full company profileagilon health Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
agilon health Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 794M | 1.22B | 1.52B | 2.39B | 4.32B | 6.06B | 5.93B | 5.91B |
| Gross Profit | 28.5M | 94.2M | 65.7M | 111M | 69.7M | 4.84M | -189M | 351M |
| Operating Income | -107M | -56.7M | -372M | -105M | -232M | -292M | -421M | 61.3M |
| EBITDA | -64.2M | -40.1M | -362M | -72.4M | -168M | -218M | -369M | 125M |
| Net Income | -283M | -60.1M | -406M | -107M | -263M | -260M | -405M | 110M |
| EPS | -18 | -3.90 | -27 | -6.53 | -16 | -16 | -24 | 6.24 |
| Balance Sheet | ||||||||
| Total Assets | 403M | 446M | 1.59B | 1.70B | 1.74B | 1.73B | 1.27B | 1.57B |
| Total Liabilities | 635M | 731M | 495M | 657M | 1.08B | 1.26B | 1.14B | 1.28B |
| Shareholders' Equity | -232M | -285M | 1.09B | 1.04B | 662M | 471M | 127M | 281M |
| Cash & Short-term Investments | 124M | 107M | 1.05B | 877M | 495M | 406M | 285M | 240M |
| Total Debt | 77.9M | 73.2M | 59.6M | 52.6M | 52.3M | 44.0M | 36.8M | 33.4M |
| Cash Flow | ||||||||
| Operating Cash Flow | -104M | -53.2M | -148M | -131M | -156M | -57.8M | -106M | 21.7M |
| Capital Expenditure | 3.91M | 2.35M | 13.4M | 32.7M | 30.8M | 13.3M | 13.2M | 13.1M |
| Free Cash Flow | -108M | -55.6M | -162M | -163M | -187M | -71.0M | -119M | 8.66M |
| Ratios | ||||||||
| ROE | - | - | -37.2% | -10.2% | -39.7% | -55.2% | -319.8% | 39.3% |
| ROA | -70.2% | -13.5% | -25.6% | -6.3% | -15.1% | -15.0% | -31.9% | 7.1% |
| Net Profit Margin | -35.6% | -4.9% | -26.7% | -4.5% | -6.1% | -4.3% | -6.8% | 1.9% |
| Debt to Equity | - | - | 0.05x | 0.05x | 0.08x | 0.09x | 0.29x | 0.12x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
agilon health Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | USD 6.87M | 0.42 | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:25 on Mar 31, 2026.
Who owns agilon health Inc
- Insiders 5.04%
- Institutions 94.96%
- Public & others 0.00%
- Shares outstanding 16.8M
- Free float 10.9M
Top funds holding AGL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 370K | 2.20% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 318K | 1.90% | 0.00% | Oct 2026 |
| Morgan Stanley Insight I | 275K | 1.63% | -14.69% | Jun 2026 |
| BrighthouseI Morgan Stanley Discovery B | 247K | 1.47% | -24.98% | Jun 2026 |
| Morgan Stanley Inst Inception I | 240K | 1.43% | +39.50% | Jun 2026 |
| EQ/Morgan Stanley Small Cap Growth K | 186K | 1.11% | +3.27% | Sep 2026 |
| Morgan Stanley Inst Discovery I | 160K | 0.95% | -32.93% | Jun 2026 |
| Schwab Fundamental U.S. Small CompanyETF | 159K | 0.95% | 0.00% | Oct 2026 |
| Fidelity Small Cap Index | 137K | 0.81% | +0.15% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 117K | 0.70% | -0.38% | Oct 2026 |
| First Trust Small Cap Gr AlphaDEX® ETF | 108K | 0.64% | +0.43% | Oct 2026 |
| Fidelity Enhanced Small Cap Core ETF | 103K | 0.62% | +0.27% | Oct 2026 |
| BlackRock Advantage Small Cap Core Instl | 101K | 0.60% | +3.99% | Sep 2026 |
| Vanguard Russell 2000 ETF | 72.5K | 0.43% | +1.19% | Sep 2026 |
| CREF Total Global Stock Account R3 | 67.8K | 0.40% | -14.47% | Aug 2026 |
| Schwab US Small-Cap ETF™ | 66.2K | 0.39% | +0.19% | Oct 2026 |
| Fidelity Extended Market Index | 57.0K | 0.34% | -6.60% | Sep 2026 |
| Nuveen Quant Small/Mid Cap Eq R6 | 48.3K | 0.29% | 0.00% | Aug 2026 |
| Nuveen Quant Small Cap Equity R6 | 46.3K | 0.28% | -15.83% | Aug 2026 |
| First Trust Small Cap Core AlphaDEX® ETF | 42.4K | 0.25% | 0.00% | Oct 2026 |
Top institutions holding AGL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Clayton Dubilier & Rice LLC | 4.00M | 23.82% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 2.01M | 11.97% | -4.20% | Jun 2026 |
| North Peak Capital Management, LLC | 1.49M | 8.84% | -3.91% | Jun 2026 |
| BlackRock Inc | 1.15M | 6.83% | +31.31% | Jun 2026 |
| AQR Capital Management LLC | 693K | 4.12% | -28.96% | Jun 2026 |
| The Goldman Sachs Group Inc | 687K | 4.09% | -35.34% | Jun 2026 |
| Vanguard Capital Management, LLC | 525K | 3.13% | -2.45% | Jun 2026 |
| Marshall Wace Asset Management Ltd | 468K | 2.79% | 0.00% | Jun 2026 |
| Durable Capital Partners LP | 441K | 2.62% | 0.00% | Jun 2026 |
| D. E. Shaw & Co LP | 390K | 2.32% | -47.43% | Jun 2026 |
| Charles Schwab Investment Management Inc | 349K | 2.08% | -4.26% | Jun 2026 |
| Geode Capital Management, LLC | 314K | 1.87% | +18.06% | Jun 2026 |
| State Street Corp | 280K | 1.67% | +10.41% | Jun 2026 |
| Jane Street Group LLC | 273K | 1.63% | +1,708.99% | Jun 2026 |
| Rock Springs Capital Management LP | 263K | 1.56% | +1.00% | Jun 2026 |
| Nuveen, LLC | 229K | 1.36% | +615.94% | Jun 2026 |
| Renaissance Technologies Corp | 152K | 0.91% | +2.13% | Jun 2026 |
| Amvescap Plc. | 133K | 0.79% | +228.46% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 128K | 0.76% | +15.78% | Jun 2026 |
| Two Sigma Investments LLC | 126K | 0.75% | +26.53% | Jun 2026 |
agilon health Inc company profile
- Company name
- agilon health Inc
- Ticker
- AGL.US
- Exchange
- USA Stocks
- Listed since
- Apr 15, 2021
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 856
- Fiscal year end
- December
- Address
- 440 Polaris Parkway, Westerville, OH, United States, 43082
- Phone
- 562 256 3800
- Website
- agilonhealth.com
About agilon health Inc
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
agilon health Inc management
9- Mr. Timothy Patrick O'RourkeCEO & Director
- Mr. Timothy GertschChief Accounting Officer · born 1987
- Mr. Varun AnandInterim Chief Technology Officer
- Mr. Evan Smith C.F.A.Senior Vice President of Investor Relations
- Mr. Bill FarryChief of Technology Innovation
- Mr. Kenny BellendirMarkets Chief Financial Officer
- Ms. Heidi HittnerChief Business Operations Officer
- Dr. Karthik Rao M.D.Chief Medical Officer
- Leland ThomasSenior Manager of Investor Relations